Area of research
Immunology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune cells in cancer, and Gut microbiota and health.
Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review
Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort study
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Canadian high arctic ice core records of organophosphate flame retardants and plasticizers
Hallmarks of Resistance to Immune-Checkpoint Inhibitors
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses
Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
508 Generalizability of predictive versus prognostic indicators from published transcriptomic associations with tumor response to immune checkpoint inhibition
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
B cells and tertiary lymphoid structures promote immunotherapy response
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis